STEPHANIE PAPA: Open Payments
NPI 1710536842 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 38 payments from 9 companies in 2025. Trend: 2023 $84 · 2024 $413 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $173 |
| AstraZeneca Pharmaceuticals LP | 10 | $154 |
| Smith+Nephew, Inc. | 2 | $138 |
| Novo Nordisk Inc | 3 | $56 |
| Lilly USA, LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: VRAYLAR, COLLAGENASE SANTYL, AIRSUPRA, MOUNJARO, Rybelsus, REXULTI, Ozempic, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
